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Abstract 
 
In spite of the therapeutic importance of Aristolochia bracteolata Linn. in Nigerian ethnomedicine, it is largely 
collected from the wild. Owing to the acclaimed potency of the plant and the difficulty in treating candidiasis, the anticandidal 
activity and in vitro propagation of the plant were investigated.  Phytochemical screening and preparation of extracts of the roots 
were done using standard procedures. Clinical isolates of Candida albicans were screened against extracts and essential oil of 
Aristolochia bracteolata root using agar-well diffusion method. Minimum Inhibitory Concentration (MIC) of the ethanol extract 
was determined using broth dilution method. The nodal cuttings of A. bracteolata were cultured on Murashige and Skoog (MS) 
basal media. A. bracteolata contained alkaloids, saponins and cardenolides. The water extract was inactive on all isolates. The 
ethanol extract (500 mg/ml) and essential oil (undiluted) exhibited anticandidal activity on 9 out of 10 isolates at 101 – 106 cfu/ml 
inoculums concentration. Green growth and callus formation were observed in explants cultured on MS basal media after 30 days. 
A. bracteolata could be a source of anticandidal phytomedicine and the in vitro propagation confirmed its sustainability as 
anticandidal agent.  
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Introduction 
 
Aristolochia is the most diverse genus of Aristolochiaceae with about 120 species distributed throughout the tropics and 
substropics (Shoko, 2002). Aristolochia bracteolata Linn. is a small glabrous shrub occurring in the Sahel zone of the region from 
Mali to Northern Nigeria, and in tropical East Africa, Arabia and India. The fresh root yields two acidic crystalline compounds, 
one with bright yellow needles, m.p. 275-2770C, is identical with aristolochic acid, the other has orange yellow needles, m.p. 240-
2520C.  The seeds also contain the same two substances and also a greenish-brown, non-drying fixed oil, an alkaloid is reported 
present in the root and stem of Indian material (Burkill, 1985).  
An infusion of the dried leaves, sometimes with the dried root added, is used in Nigeria by Hausa and Fulani as 
anthelmintic, a use that is also known in India. The freshly bruised leaves are mixed with castol-oil and used in Nigeria topically 
on pimples.  In India the plant is used to treat scabies, and in the Ogaden of Ethiopia on leg itch.. The root is bitter.  Roots mixed 
with lime juice are taken for snake bite and scorpion stings in Nigeria. East of Lake Chad also the root is applied to scorpion 
stings. The flowers are sometimes worn in Northern Nigeria as charm against snake-bite and scorpion-stings (Burkill, 1985). The 
use of the plant as antibiotics, antimalarial and aphrodisiac has been reported by traditional healers of Southwestern Nigeria. Negi 
et al.(2003) reported that it is used as a gastric stimulant and in the management and treatment of cancer, lung inflammation and 
dysentery. 
There have been growing interests in the investigations of the natural products from plants with the aim of discovering 
new antibiotics agents as well as alternative routes for the substitution of synthetic chemicals. In view of this, the essential oil and 
extract of many plants have been prepared and screened for their antimicrobial activities leading to the accumulation of a large 
number of reports in the literature (Akande et al., 2004; Abo and Olugbuyiro, 2004). 
Vaginal candidiasis (vaginal thrush) is one the most common genital infections.  The yeast Candida albicans can be isolated in 
the vagina fluids of over 80% of affected patients. Opportunistic fungal infections are responsible for increased mortality among 
patients immunocompromised as a result of cancer chemotherapy and organ transplantation.  Resistances to drugs as well as 
limiting toxic effects have stimulated the search for new groups of antimycotic agents (Rai et al. 2003).  
The methanol residual aqueous fraction and direct aqueous fraction of Thalictrum rhynchocarpum showed reasonable 
antimicrobial activity against E. coli, Staphylococcus aureus, Salmonella gallinum and Candida albicans (Desta, 1993). Essential 
oil from Aloysia triphylla and Mentha piperita were able to control the yeast Candida albicans using bioautographic method 
(Sartoratto et al, 2004).  Hammer et al. (1999) reported the anticandidal activity of thyme oil. The lowest minimum inhibitory 
concentrations were 0.03% (v/v) thyme oil against C. albicans and Escherichia coli. 
Micropropagation has proved to be an alternative for the multiplication of selected genotype and chemotype of several 
medicinal and aromatic plants (Bajaj et al. 1995). As there has been relatively few information in literature on micropropagation 
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of Nigerian medicinal plants, the present work aims at contributing to this aspect of medicinal plant research, by searching for 
sustainable indigenous anticandidal phytomedicine. 
 
 
 
Materials and Methods 
Plant material  
 
Fresh and healthy plant materials collected during the raining season from University of Ibadan campus were used in the 
experiments.  The sample was identified in the University of Ibadan Herbarium (UIH). The roots were thoroughly washed with 
tap water, air-dried, powdered and stored in an air-tight glass container for further use. 
 
Phytochemical screening 
 
The powdered sample was screened for the presence of natural products using standard procedures in the laboratory of 
the Department of Pharmacognosy, University of Ibadan, Ibadan, Nigeria. 
 
Preparation of extracts and essential oil 
 
           Water extract: Exactly 200 g of the dried powdered sample was soaked in 1000 ml of sterile distilled water for 48 h. The 
mixture was filtered and the filtrate was freeze dried. 5g of the extract was reconstituted in 5 ml sterile distilled water to obtain a 
solution of 1000mg/ml, which was used for the anticandidal screening. Ethanol extract: 500 g of powdered sample was extracted 
in 1.5 litre of ethanol (95 % w/v) for 24 h using Soxhlet apparatus. The extract was transferred into sample holder of the rotary 
vacuum evaporator, where the extract was concentrated to dryness at 500C and then air – dried to constant weight. The extract was 
refrigerated at 40C prior to use. 5g of the extract was reconstituted in 10 ml sterile distilled water to obtain a solution of 
500mg/ml, which was used for the anticandidal screening. Essential oil: Essential oil was extracted from 300g of the powdered 
sample (4h) by hydrodistillation using a Clavenger – type apparatus designed to the British pharmacopoeia specification (1980). 
The essential oil was stored in the refrigerator at 40C prior to use. The undiluted oil was used for the anticandidal screening.  
 
Identification of Candida albicans isolates 
 
The Candida albicans isolates were identified according to the methods used by Gbadamosi and Egunyomi (2008). 
 
Assay of plant extracts for anticandidal activity by agar-well diffusion method 
 
The extracts were tested for their anticandidal activity using agar well diffusion method. Each microorganism was 
suspended in sterile malt extract broth (Difco Laboratories, USA), incubated at 35 + 20C for 18 h. Different concentrations (serial 
dilution) of inoculum were prepared from the broth in sterile distilled water to give a range of concentrations at Ca.101-106 colony 
forming unit (cfu) per ml.  They were seeded in sterile Mueller Hilton agar (LAB M, UK.) containing 9 mm wells. 50 µl of extract 
were introduced into wells and incubated as previously described. Zones of inhibition were measured in millimetres. A control 
plate containing the test organism without any plant extract was also incubated. All the work done was aseptically carried out. 
Each examination was carried out in triplicates for all isolates.  The MIC was also determined using dilution method. The 
dilutions of the ethanol extract to be tested were prepared in 5.0 ml volumes of sterile nutrient broth to give a range of 
concentration from 5,000 to 0.020 mg/ml.  After preparation of suspensions of test organisms Ca. 106 organisms per ml, 0.1 ml 
was added to the extract/broth dilutions (Atalay et al., 1998). For control experiment, 200mg tablet of metronidazole (May and 
Baker, Nigeria) was dissolved in 200 ml of sterile distilled water to give a concentration of 1 mg/ml, The dilutions of 
metronidazole to be tested were prepared in 5.0 ml volumes of sterile nutrient broth to give a range of concentration from 1 to 
0.020 mg/ml, that was used for the MIC test. After 18 hours incubation at 35 + 20C, the tubes were then examined for growth. 
 
Assay of essential oil by agar-well diffusion method 
 
All overnight cultures were grown in malt extract broth at 35 + 20C for 18 hours.  The inoculum load was adjusted to 1 
x 106 organisms per ml prior to use. 1 ml of this concentration of inoculum was added and thoroughly mixed with 19 ml of sterile 
liquid Mueller Hilton agar and poured (aseptically) into sterilized Petri-dishes.  The agar was allowed to solidify.  From each plate 
6mm diameter wells (two wells per Petri dish) were cut from the agar using sterile cork-borer, each of these wells was aseptically 
filled with 50 µl of undiluted essential oil of plant samples or sterile nutrient broth (control). The plates were incubated at 35 + 
20C for 18-38 hours and zones of inhibition were recorded in millimetres (mm) (Jennie et al., 2003). 
 
Micropropagation 
 
Fresh and healthy plant materials (nodal cuttings) collected during the raining season from University of Ibadan campus 
were used as explants in the experiments.  The pH of each medium was adjusted to 5.7 prior to the addition of 0.7 % agar (Difco, 
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USA). Media and instruments were sterilized by autoclaving for 15-30 min at 1210C (1 atm). Aseptic transfers were performed in 
a laminar flow hood (Bottino, 1981). The explants were washed thoroughly with liquid detergents and rinsed properly with sterile 
distilled water. They were washed with 70% ethanol solution for 5 minutes subsequently surface-sterilized with 10% sodium 
hypochloride for 20 minutes and 5% sodium hypochloride for 10 minutes.  The explants were properly rinsed with sterile distilled 
water 3times, leaving the explants in the third rinse.  The nodal cuttings were aseptically implanted vertically on the sterile culture 
medium in glass tubes (20 x 150 mm) using sterile forceps.  After inoculation in the different nutrient media, the glass-tubes were 
sealed with paraffin wax and labelled. The cultures were incubated at 24 + 20C with a photoperiod of 16 hours at an intensity of 
10-20 µmol m-2S-1 (Phillips ThD 36W/84) in the growth room for a period of 30 - 90 days. Each treatment was replicated three 
times. 
 
Statistical analysis 
 
Analysis of variance and comparison of means were carried out on all data using Statistical Analysis System (SAS). 
Differences between means were assessed for significance at P ≤ 0.05 by Duncan,s multiple range test (DMRT). 
 
 
 
Results 
 
 Table 1 shows that A. bracteolata contains alkaloids, cardenolides and saponins while anthraquinones and tannins were 
absent. The inhibitory behaviour of ethanol extract of Aristolochia bracteolata on Candida albicans isolates is presented in Table 
2. The extract demonstrated inhibitory activity against 9 out of 10 tested Candida albicans isolates.  The least zone of inhibition 
ranges from 14.00 mm to 15.00 mm in isolate C04, while the highest inhibition zone ranges from 19.00 mm to 50.00 mm on 
isolate C07.  Thus, the ethanol extract of Aristolochia bracteolata was most active on isolate C07 and least active on isolate C04, 
while it was totally inactive on isolate C01 at all inoculum loads used.  The ethanol extract of A. bracteolata inhibited all the 
tested isolates with MIC values ranging between 20 and 1500 µg/ml (Table 3).  The inhibitory effect of essential oil of the plant  
is presented in Table 4.  The essential oil of A. bracteolata demonstrated inhibitory activity on 9 out of 10 isolates screened.  Its 
highest activity was on isolate C07 with inhibition zone of 52.50 mm, followed by 42.50 mm on isolate C09 and the least activity 
was on isolates C05 and C08 which had 15.50 mm each. Table 5 shows the growth response of the nodal cuttings of Aristolochia 
bracteolata on MS basal media. The formation of calluses was observed (Plate 1). 
 
Table 1: Phytochemical screening of Aristolochia bracteolata roots 
 
Phytochemical constituents Powdered roots 
Alkaloids + 
Anthraquinones - 
Cardenolides + 
Saponins + 
Tannins - 
                                                   Legend: + = Present; - = absent 
 
Table 2: Inhibitory behaviour of ethanol extract of Aristolochia bracteolata against Candida albicans isolates at different 
concentrations of inoculum 
 
Inoculum load (cfu/ml) / zone of inhibition (mm) 
 
C. albicans isolate 
 
1.0 x 101 
 
1.0 x 102 
 
1.0 x 103 
 
1.0 x 104 
 
1.0 x 105 
 
1.0 x 106 
C01 *0.00 + 0.00 a 0.00 + 0.00 a 0.00 + 0.00 a 0.00 + 0.00 a 0.00 + 0.00 a 0.00 + 0.00 a 
C02 14.00 + 0.00a 17.50 + 0.70ab 20.00 + 0.07ab 22.00 + 2.43abc 30.00 + 0.00c 25.00 + 0.00bc 
C03 14.00 + 2.82ab 16.00 + 0.00ab 12.00 + 0.00a 20.00 + 2.82b 27.50 + 3.53c 27.00 + 3.53c 
C04 14.00 + 1.41a  14.00 + 1.41a 14.00 + 1.41a 14.50 + 2.12a 14.00 + 1.41a 15.00 + 0.00a 
C05 13.00 + .00a 14.00 + 1.41ab 16.00 + 1.41bc 13.00 + 1.41a 15.00 + .00abc 17.50 + 0.70c 
C06 12.00 + .00a 13.00 + 1.41a 14.00 + 2.82a 16.00 + 0.00a 17.50 + 3.53a 21.00 + 0.07a 
C07 19.00 + 1.41a 21.00 + 1.41a 22.00 + 2.82a 23.50 + 2.12a 21.00 + 1.41a 50.00 + 0.00b 
C08 20.00 + 0.00bc 16.50 + 2.12a 18.00 + 0.00ab 22.00 + 0.00c 27.00 + 0.00d 27.00 + 0.00d 
C09 19.50 + 0.70a 20.50 + 0.70a 19.50 + 0.70a 22.50 + 0.70b 29.50 + 0.70c 29.50 + 0.70c 
C10 18.00 + 0.00a 17.50 + 0.70a 17.50 + 0.70a 23.50 + 0.70b 24.50 + 0.70b 45.50 + 0.70c 
Legend: *Mean of three readings + standard deviation. 
*Values in the same column followed by the same letter are not significantly different (p>0.05) from each other. They differ 
significantly (p≤0.05) with values that do not share a similar letter. 
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Table 3: Minimum inhibitory concentration (MIC) of ethanol root extract of Aristolochia bracteolata 
            
Candida albicans isolates / minimum inhibitory concentration (µg/ml)  
Plant   C01 C02 C03 C04 C05 C06 C07 C08 C09 C10 
A.bracteola
ta 
*20.00 + 
0.00 
100.00 + 
0.00 
100.00 + 
0.00 
100.00 + 
0.00 
20.00 + 
0.00 
100.00 + 
0.00 
20.00 + 
0.00 
20.00 + 
0.00 
20.00 + 
0.00 
1500.00 + 
0.00 
 
Metronid- 
Azole  
 
40.00  
+ 0.00 
 
40.00 
 + 0.00 
 
40.00  
+ 0.00 
 
20.00  
+ 0.00 
 
40.00  
+ 0.00 
 
40.00  
+ 0.00 
 
40.00  
+ 0.00 
 
20.00  
+ 0.00 
 
20.00  
+ 0.00 
 
20.00  
+ .00 
Legend: *Values represent Mean ± SD. (n = 3) 
 
 
Table 4: Inhibitory behaviour of essential oil of roots of Aristolochia bracteolate on Candida albicans isolates  
 
Candida albicans isolates (106 cfu/ml) / zone of inhibition (mm)  
Test oil 
(undiluted) 
C01 C02 C03 C04 C05 C06 C07 C08 C09 C10 
Aristolochia 
bracteolata 
*19.50  
+ 3.86 
34.00 
+3.86   
0.00 + 
3.86 
25.50 + 
3.86 
15.50 + 
3.86 
26.50 + 
3.86 
52.50 + 
3.86 
15.50 + 
3.86 
42.50 + 
3.86 
20.50 + 
3.86 
  Legend: Diameter of the cork borer = 6.00 mm. 
*Values represent Mean ± SD. (n = 3) 
 
 
Table 5: The growth response of Aristolochia bracteolata nodal cuttings on MS basal   media after 30days in culture. 
 
Media                    Observation 
MS only                  20 %  callus formation 
MS + NaH2 PO4. H2O (170 mg/L)                           Green growth 
MS + 2,4-D (0.5 mg/L)                  50 % callus formation 
MS + NAA (0.01mg/L) + BAP (0.05 mg/L)                  Green growth 
MS + NAA (0.02 mg/L) + BAP (2.5 mg/L)                  Green growth 
MS + NAA (0.04 mg/L) + BAP (3.5 mg/L)                  Green growth 
Legend: 
MS = Murashige and Skoog salt base (Murashige and Skoog, 1962) 
NaH2P04.H20 = Sodium dihydrogen ortho phosphate 
NAA = 1-napthalene acetic acid 
BAP = Benzyl aminopurine 
2, 4-D = 2, 4-dichlorophenoxyacetic 
 
 
 
Plate 1: Growth of Aristolochia bracteolata (nodal cutting) on MS + 2, 4-D (0.5 mg/L).  
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Discussion 
 
The analysis of phytochemical properties of the plant sample revealed the presence of secondary metabolites. Many 
vegetable drugs owe their action to alkaloids, which are nitrogenous compounds.  In plants, the alkaloids generally occur 
combined with acids as salts. The toxic action of alkaloids against lower forms of animal life is made use of in their application as 
anthelmintics, antiparasitics and used in local settings as fish poisons. The antibiotic effect is used in the specific treatment of 
certain infections (Oliver, 1960). An example of the effect of phytochemical constituent of medicinal plant on their possible 
therapeutic use is the use of Aristolochia bracteolata as stomachic because of its bitter principle (Oliver, 1960). 
The ethanol extract of Aristolochia bracteolata was very active (90%) on isolates of Candida albicans. Hussein (1970) 
isolated aristolochic acid, aristo red and yellow acidic compounds from the ethereal extract of the alcoholic extract residue of the 
defatted seeds of Aristolochia bracteolata, the quaternary fraction of this alcoholic extract gave a major crystalline alkaloid 
identified as magnoflorine (thalactrine) along with two minor alkaloids (A and B) in trace quantities. A related species - A 
.elegans – was found to contain five alkaloids and sterols in the leaves as well as allantoin, aristo red, and magnoflorin in the root 
(Hussein and El-Sebakhy, 1980). Also Goncalves de Lima et al. (1952, cited in Sofowora, 1982) identified and separated two 
substances, A and B. The properties of the two substances were reported to be similar except that B was less soluble than A in 
ether. The two substances A and B were tested for antimicrobial activity. The bactericidal activity of A (purified 
chromatographically) was 1.281.7 u/ml against Micrococcus pyogenes, 2.4u/ml against M. citreus and 3u/ml against Bacillus 
anthracis. Mesa-Alicia et al (1950) also reported that the extracts from the roots of Aristolochia species strongly inhibited the 
cultures of Staphylococcus aureus. Kavitha and Nirmaladevi (2007) assessed the biotherapeutic potential of extracts A. 
bracteolata and reported its antimicrobial activity against bacterial and fungal strains. These antimicrobial properties of the plant 
probably explain its strong activity on isolates of C. albicans in the present work and its traditional use for treating sores and skin 
diseases. Shirwaikar et al. (2003) reported the positive wound healing effect of ethanol extract of Aristolochia bracteolata. El 
Tahir et al. (1999) studied the in vitro antiplasmodial activity of eleven Sudanese medicinal plants against Plasmodium falciparum 
3d7 (chloroquine resistant and pyrimethamin sensitive). Plant extracts from Gardenia lutea, Haplophyllum tuberculatum, Cassia 
tora, Acacia nilotica and Aristolochia bracteolata possessed IC (50) values less than 5 microg/ml on both tested strains. 
 It is remarkable to note that Candida albicans isolates C02, CO3, CO4, CO6 and C10 had higher susceptibility to the 
ethanol extracts of Aristolochia bracteolata than metronidazole (standard reference drugs). The oil of Aristolochia bracteolata 
was active on 9 out of 10 isolates. This is an indication that the essential oil contain active anticandidal agent.  The 
micropropagation experiment of Aristolochia bracteolata showed the production of calluses on MS basal media. Plantlets can be 
regenerated from calluses to ensure the sustainability of A. bracteolata as an anticandidal phytomedicine.  
 
Conclusion 
 
Based on this work showing significant anticandidal activities that were exhibited by the ethanol extract and essential 
oil of A. bracteolate and because of the popularity of the plant in management and treatment of infections in Nigeria, the plant 
could be a good source of development of anticandidal phytomedicine. Its micropropagation would ensure its sustainability in 
Nigerian ethnobotany. 
 
 
 
Acknowledgement 
 
The Authors are grateful for the scientific assistance provided by the entire staff of the Tissue Culture Laboratory, 
National Center for Genetic Resources And Biotechnology (NAGRAB), Ibadan, Nigeria. 
 
 
 
References 
 
1.          Abo, K.A. and Olugbuyiro, J.A.O. (2004).  Phytochemical and antibacterial studies of extracts of Flabellaria 
paniculata.  African Journal of Biomedical Research 7: 35 - 36. 
2.          Akande, O.O., Alada, A.R.A., Aderiniokun, G.A. and Odigwe, F.A. (2004).  A laboratory evaluation of the efficacy of 
an herbal dentifrice on dental caries in the rat.  African Journal of Biomedical Research 7: 89 - 92. 
3.           Bajaj, Y.P.S (Ed.) (1995).  Biotechnology in Agriculture and Forestry 32: Cryopresevation of   Plant Germplasm 1. 
Springer, Berlin, 512 pp.  
4.          Bottino, P.J. (1981).  Methods in plant tissue culture.  Kemtec Educational Corp., Kensington, Maryland. 72. 
5.          British Pharmacopoeia (1980). Her Majesty,s Stationary Office. 2: 109. 
6.          Burkill, H.M. (1985).  The useful plants of West Tropical Africa.  Royal Botanic Gardens Kew, 2nd edition, Vol. 1: 
Families A-D. Pp. 215; 228; 443; 444; 597 and 599. 
7.          Desta, B. (1993). Ethiopia traditional herbal drugs Part II: Antimicrobial of 63 medicinal plants. Journal of 
Ethnopharmacology 39: 129 - 139. 
Gbadamosi and Egunyomi  Afr J Tradit Complement Altern Med. (2012) 9(1):50-55 
http://dx.doi.org/10.4314/ajtcam.v9i1.7 
55
8.           El Tahir, A., Satti, G.M. and Khalid, S.A. (1999).  Antiplasmodial activity of selected Sudanese medicinal plants with 
emphasis on Acacia nilotia. Phytomedicine 13(6): 474 - 478. 
9.           Gbadamosi, I. T. and Egunyomi, A. (2008). In-vitro anticandidal activity of extracts and essential oil of roots of 
Plumbago zeylanica Linn. (Plumbaginaceae). Nigerian Journal of Botany 21(2): 286 - 297. 
10. Hammer, K.A., Carson, C.F. and Riley, T.V.  (1999). Antimicrobial activity of essential oil and other plant extracts.  
Journal of Applied Microbiology 88: 985 - 990. 
11. Hussein, F.T. (1970).  Phytochemical investigation of the seeds of Aristolochia bracteolata Retz, Planta Medica 18(1): 
30 - 35. 
12. Hussein, F.T. and El-Sebakhy, N.A. (1980).  Phytochemical investigation of the root of Aristolochia elegans. 4th Asian 
symposium on medicinal plants and spices, Bangkek, Thailand, September. Book of Abstracts, p. 115. 
13. Jennie, R. Hood, Jenny, M. Wilkinson and Heather M.A. Cavanagh (2003).  Evaluation of Common Antibacterial 
screening methods utilized in Essential oil research. Journal of Essential Oil Research 15: 428 - 433. 
14. Kavitha, D. and Nirmaladevi, R. (2007). Assessement of Aristolochia bracteolata leaf extracts for its biotherapeutic 
potential. African Journal of Biotechnology 8 (17): 4242 - 4244. 
15. Mesa-Alicia, M., Jesus Guzman, Craviotto, R. and Calvo De la Tori, J.  (1950). Antibiotic properties of Artistolochia. 
Ciencia  e Invest. (Buenos Aire) 6: 471 - 476. 
16. Negi, P. S.,Anandharamakrishnan, C. and Jayaprakasha, G. K. (2003). Antibacterial activity of Aristolochia bracteolata 
roots extracts. J. Med. Food 6(4): 401- 401. 
17. Oliver, B. (1960). Medicinal plants in Nigeria.  The Nigerian College of Arts, Science and Technology.  Pp. 93 - 124. 
18. Rai, M.K., Deepak, A. and Wadegaonkar, P. 2003. Plant derived-antimycotics; potential of Asteraceous plants, In: 
Plant-derived antmycotics; Current Trends and Future Prospets, Haworth Press, New York, London, Oxford, pp. 165-185. 
19. Sartoratto, A., Ana Lucia M., Machado., Camila Delarmelina., Glyn Mara Figueira., Marta Cristina T., Duarte., Vera 
Lucia G., Rehder. (2004). Composition and antimicrobial activity of essential oil from aromatic plants used in Brazil.  
Brazilian Journal of Microbiology 35: 275 - 280. 
20. Shirwaikar, A., Somashekar, A.P., Udupa, A.L. and Somashekar, S. (2003).  Wound healing studies of Aristolochia 
bracteolata Linn. with supportive action of antioxidant enzymes.  Phytochemical, volume 10, issue 6-7. Pages 558 - 562. 
21. Sofowora, A. (1982).  Traditional Medicine: Definitions and Terminology.  In: Medicinal Plants and Traditional 
Medicine in Africa.  1st edn. John Wiley and Sons, pp. 256. 
 
 
 
 
 
 
